Most comprehensive USA clinical trial to date shows competing medicated stents work equally well
A comprehensive US clinical trial reveals that competing medicated stents are equally effective in preventing target vessel re-vascularization (TVR) and major adverse cardiac events (MACE). The STENT registry, a nationwide study involving over 14,000 patients, provides insights into the efficacy of drug-eluting stents.